A previously well 4‐month‐old boy was admitted to a tertiary Victorian paediatric hospital in February 2022 following a febrile convulsion. He had a 2‐day prodrome characterised by fevers to 39°C and reduced energy and feeding. The self‐limiting febrile convulsion occurred on day 3 of illness and was characterised by left eye deviation, tonic extension of upper limbs, shallow breathing, and pallor. He did not appear unwell on initial examination and no convincing source of fevers was identified. He was born at term and was developing appropriately for age.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. National Pest and Disease Outbreaks. Japanese encephalitis [website]. https://www.outbreak.gov.au/current‐responses‐to‐outbreaks/japanese‐encephalitis (viewed Apr 2022).
- 2. Australian Government Department of Health. Japanese encephalitis virus (JEV) [website]. https://www.health.gov.au/health‐alerts/japanese‐encephalitis‐virus‐jev/about (viewed May 2022).
- 3. Misra UK, Kalita J. Overview: Japanese encephalitis. Prog Neurobiol 2010; 91: 108‐120.
- 4. Chin R, Torresi J. Japanese B encephalitis: an overview of the disease and use of Chimerivax‐JE as a preventative vaccine. Infect Dis Ther 2013; 2: 145‐158.
- 5. Turtle L, Solomon T. Japanese encephalitis — the prospects for new treatments. Nat Rev Neurol 2018; 14: 298‐313.
- 6. Australian Government Department of Health. ATAGI clinical guidance on Japanese encephalitis virus vaccines [website]. https://www.health.gov.au/health‐alerts/japanese‐encephalitis‐virus‐jev/clinical‐guidance (viewed Apr 2022).
- 7. Australian Government Department of Health. Japanese encephalitis [website]. https://www.health.gov.au/health‐topics/japanese‐encephalitis (viewed Apr 2022).
- 8. Semenza JC, Menne B. Climate change and infectious diseases in Europe. Lancet Infect Dis 2009; 9: 365‐375.
No relevant disclosures.